Top 50 Medical Angel Investors in United Kingdom (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Jonathan Milner
Angel
|
13 | United Kingdom, United States, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $537k–$56M |
|
Mark Bamforth
Angel
|
3 | United Kingdom, United States | Series A, Seed | Health Care, Medical, Biotechnology | $2M–$21M |
|
Ian Hogarth
Angel
|
2 | United Kingdom, United States, Germany | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, SaaS | $698k–$43M |
|
Richard Reed
Angel
|
2 | United Kingdom, United States, The Netherlands | Seed, Series A, Venture - Series Unknown | E-Commerce, Consumer Goods, Food and Beverage | $1.1M–$19M |
|
Will Brooks
Angel
|
2 | United Kingdom, United States | Seed, Series A | Financial Services, FinTech, Software | $524k–$30M |
|
Ariel Poler
Angel
|
2 | United States, Spain, Mexico | Seed, Series A, Angel | Social Media, Software, Apps | $455k–$7.9M |
|
Alexander Chesterman
Angel
|
2 | United Kingdom, France | Seed, Pre-Seed, Series A | E-Commerce, FinTech, Health Care | $470k–$24M |
|
Jan Hruska
Angel
|
2 | United Kingdom | Seed, Venture - Series Unknown | Medical, Health Care, Life Science | |
|
Nicholas Edwards
Angel
|
2 | United Kingdom | Seed, Venture - Series Unknown | Medical, Health Care, Life Science | |
|
Taavet Hinrikus
Angel
|
2 | United Kingdom, United States, Estonia | Seed, Series A, Series B | FinTech, Software, Financial Services | $1.4M–$58M |
|
Matt Clifford
Angel
|
2 | United Kingdom, United States, India | Seed, Pre-Seed | Software, FinTech, Artificial Intelligence | $55k–$7M |
|
Justin Mateen
Angel
|
2 | United States, Mexico, United Kingdom | Seed, Series A, Pre-Seed | Software, E-Commerce, Health Care | $400k–$30M |
|
Finn Russell
Angel
|
2 | United Kingdom | Angel, Venture - Series Unknown | Fitness, Medical, Wellness | |
|
Will Martin
Angel
|
2 | United Kingdom, United States, Japan | Seed, Series A, Pre-Seed | Software, Financial Services, FinTech | $650k–$11M |
|
Michael Pennington
Angel
|
2 | United Kingdom, United States, Spain | Seed, Pre-Seed, Venture - Series Unknown | Software, SaaS, Financial Services | $690k–$3.1M |
|
Matt Robinson
Angel
|
2 | United Kingdom, United States, France | Seed, Pre-Seed, Series A | Software, FinTech, Financial Services | $650k–$50M |
|
Alex Macdonald
Angel
|
2 | United Kingdom, United States, France | Pre-Seed, Seed, Series B | Software, Artificial Intelligence, Health Care | $327k–$50M |
|
Sachin Agrawal
Angel
|
1 | United Kingdom | Series A | Medical, Health Care, Health Diagnostics | |
|
Johnathan Matlock
Angel
|
1 | United Kingdom | Seed, Pre-Seed | Biotechnology, Medical, Health Care | |
|
Brian Souter
Angel
|
1 | United Kingdom | Medical, Commercial, Health Care | ||
|
Yusuf Hamied
Angel
|
1 | United Kingdom | Seed | Medical, Medical Device | |
|
Carlos Ballarati
Angel
|
1 | United Kingdom | Pre-Seed | Medical, Database, Consulting | |
|
Anand Mahindra
Angel
|
1 | India, United States, United Kingdom | Seed, Angel, Series A | Education, Artificial Intelligence, Social Media | |
|
Jim Mellon
Angel
|
1 | United Kingdom | Series A | Medical, Health Care, Pharmaceutical | |
|
Charlotte Scott
Angel
|
1 | United Kingdom | Seed | Medical, Health Care, Pharmaceutical | |
|
Phil Kirby
Angel
|
1 | United Kingdom | Seed | Medical, Hospital, Medical Device | |
|
Harry Glorikian
Angel
|
1 | United States | Series A | SaaS, Content, Analytics | |
|
Peter Job
Angel
|
1 | United Kingdom | Medical, Software, Pharmaceutical | ||
|
Michael Bibby
Angel
|
1 | United Kingdom | Seed | Medical, Hospital, Medical Device | |
|
Simon Kruger
Angel
|
1 | United Kingdom | Pre-Seed | Medical, Database, Consulting | |
|
Dieter Spälti
Angel
|
1 | United Kingdom | Series A | Medical, Software, Health Care | |
|
Catherine Lenson
Angel
|
1 | United Kingdom, Israel | Seed, Pre-Seed, Grant | Software, Information Technology, Internet | |
|
Stephen Bourke
Angel
|
1 | United Kingdom | Pre-Seed, Angel | Health Care, Medical, Wellness | |
|
Elan Katz
Angel
|
1 | United Kingdom | Seed | Medical, Health Care, Medical Device | |
|
Simon Franks
Angel
|
1 | United Kingdom, Australia, United States | Seed, Pre-Seed, Series A | FinTech, Health Care, Payments | $323k–$23M |
|
Ian Noel
Angel
|
1 | Spain, United States, United Kingdom | Seed, Series A | Pet, Education, Film | |
|
Jag Singh
Angel
|
1 | Germany, United Kingdom, United States | Pre-Seed, Seed, Angel | Software, FinTech, Artificial Intelligence | $120k–$4.5M |
|
Martin Varsavsky
Angel
|
1 | United States, United Kingdom, Spain | Seed, Series A, Angel | Software, Health Care, Social Media | $212k–$77M |
|
Tim Davis
Angel
|
1 | United States, United Kingdom, Germany | Series A, Series B, Seed | Health Care, Medical, Biotechnology | |
|
David Evans
Angel
|
1 | Israel, United States, United Kingdom | Series A, Series D, Series E | Software, SaaS, Rental | |
|
John Lloyd
Angel
|
1 | United Kingdom | Seed, Equity Crowdfunding, Venture - Series Unknown | Health Care, Wellness, Education | $186k–$655k |
|
Julien Codorniou
Angel
|
1 | France, United Kingdom, United States | Seed, Series A, Pre-Seed | Software, E-Commerce, Artificial Intelligence | $125k–$23M |
|
Curtis Chambers
Angel
|
1 | United States, United Kingdom, Canada | Seed, Series A, Pre-Seed | Internet, Artificial Intelligence, GPS | $11M–$18M |
|
Bashar Hamood
Angel
|
1 | United States, India, United Kingdom | Seed, Pre-Seed, Series A | Information Technology, Software, E-Commerce | $5k–$5M |
|
Carlos Gallardo
Angel
|
1 | Spain, United Kingdom | Seed, Series A | Health Care, Medical Device, Medical | |
|
Andrew Fisher
Angel
|
1 | United Kingdom | Series A | Medical, Life Science, Biotechnology | |
|
Imran Hakim
Angel
|
1 | United Kingdom | Seed | Medical, Health Care, Medical Device | |
|
Arjun Desai
Angel
|
1 | United Kingdom | Seed | Medical, Health Care, Medical Device | |
|
Jim Breyer
Angel
|
1 | United States, United Kingdom, Singapore | Series B, Series A, Seed | Artificial Intelligence, Software, Health Care | $6M–$150M |
|
Tim Ringel
Angel
|
1 | Germany, United States, Sweden | Seed, Series A, Angel | E-Commerce, FinTech, Software | |
| Access all 165 angel investors in United Kingdom Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 63
- Round size: Seed $537k–$25M; Series A $4.5M–$50M; Series B $1.6M–$56M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Quibim — Quibim builds AI tools that turn MRI, CT and PET data into actionable predictions for hospitals and biopharma. Trusted in 230+ centers worldwide.
- Nuclera — Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Mark Robert Bamforth is based out of Boston, Massachusetts and is the Chief Executive Officer of disAMR and Executive Advisor of Ampersand Capital Partners. Mark previously worked at Kincell Bio as a Chief Executive Officer. Mark Robert Bamforth attended the Henley Business School.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 15
- Round size: Seed $2M–$7M; Series A $9.2M–$21M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
- PneumoWave — PneumoWave is developing real-time monitoring solutions to allow patients with respiratory conditions and their doctors to track their respiratory rates and performance out of hospital, at home and at work. Combining proprietary sensor technology and an innovative AI driven digital therapeutic software platform, PneumoWave's technologyenables doctors to rationalise medication use, identify early signs of deterioration, reduce or shorten hospital admissions and reduce face to face appointments.
- Thymmune Therapeutics — United Therapeutics is a biotechnology company focused on creating unique products to address the medical needs of patients with chronic illnesses.
Ian Hogarth is based out of London, England, and is the Chairman of Phasecraft. Ian previously worked at Songkick as a Chairman. Ian Hogarth attended the University of Cambridge.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 62
- Round size: Seed $1.7M–$14M; Pre-Seed $698k–$7.5M; Series A $11M–$43M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
- Cordless — Bridging the gap between voice and text
- Fabric — Fabric is an AI-powered workspace and file manager for people and groups.Fabric is a self-organizing multiplayer workspace.
Richard is the founder of Innocent Drinks, UK's number 1 smoothie brand. In 2009 The Coca-Cola Company acquired a minority stake in Innocent Drinks and in 2013 the stake was increased to over 90%. Innocent Drinks gives 10% of its profits to charity. Richard is known to have implemented a google-like working atmosphere at InnocentDrinks' offices, where people feel like at home. He appeared in sereval high profile TV shows and documentaries, here is a documentary with Peter Jones from Drangon's Den (UK's equivalent of Shark Tank) He is now a successful investor through his company JamJar Investments, where they invest in strong teams with an idea that consumers love.
Show more...Investment focus
- Industry: E-Commerce, Consumer Goods, Food and Beverage
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United Kingdom, United States, The Netherlands
Investor stats
- Total investments: 20
- Round size: Seed $1.1M–$6.8M; Series A $1.5M–$19M; Venture - Series Unknown $6.1M–$9.4M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Simba Sleep — One Mattress. Five Layers of Comfort. Tailored to Suit All. Bringing together experience & technology so that your mattress gives you the best night's sleep.
- Beckley Psytech — Our mission is to help people suffering from neurological and psychiatric conditions by developing our pipeline of psychedelic compounds.
- Beckley Canopy Therapeutics — Beckley Canopy Therapeutics is a biopharmaceutical company designed to research cannabis health products.
Will Brooks - Founder & Director @ Portfolio Ventures
Show more...Investment focus
- Industry: Financial Services, FinTech, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 72
- Round size: Seed $524k–$3.5M; Series A $2.2M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bequest — Digital estate planning made easy for professionals and individuals. Securely protect online accounts, cryptocurrencies, emails, media, documents and more.
- Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
- Robin — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.
Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.
Show more...Investment focus
- Industry: Social Media, Software, Apps
- Stage:Seed, Series A, Angel
- Geography: United States, Spain, Mexico
Investor stats
- Total investments: 46
- Round size: Seed $455k–$7M; Angel $1M–$1.7M; Series A $3M–$7.9M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Goin — Goin is a Barcelona-based fintech platform founded in 2017 that provides a unified money optimization ecosystem combining automated savings, investments, digital assets, and rewards. The app enables users to aggregate multiple bank accounts via PSD2, centralizing financial data and automating decisions through its AI engine, gaIA. Goin integratesfinancial automation, portfolio tools, and cash-back incentives in a single interface used primarily by young European consumers. The company operates in a regulated environment, is registered with the Bank of Spain as a crypto service provider, and has expanded across Southern Europe. In 2025, Goin launched KernelPay, its B2B Banking-as-a-Service (BaaS) infrastructure for payments, accounts, and wallet management.
- Reloadly — Send gift cards, airtime & payouts globally with one API. Scalable, instant, developer-friendly platform for rewards and incentives.
- Openlytics — Openlytics is a Visual Data Platform. It allows Data Workers to create pipelines for data transformation and analysis, in a visual way. Our mission is to empower everyone in the organization to solve data problems, without waiting for developers.Openlytics is an early-stage company, looking to build a founding team that can shape the direction ofthe product. We’re seed-funded, remote-first, and hiring.If you're interested in learning more, email us at hello@openlytics.io.
Alex Chesterman is the Co-Founder of Houseful. Alex Chesterman attended the University College London.
Show more...Investment focus
- Industry: E-Commerce, FinTech, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, France
Investor stats
- Total investments: 45
- Round size: Seed $523k–$5.2M; Pre-Seed $470k–$3M; Series A $2.3M–$24M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Atheni AI — Atheni focused on embedding AI guidance directly into day-to-day workflows rather than relying on standalone training sessions or workshops.
- Zefir — An all-in-one platform that allows people to sell or buy in one simple, certain transaction
- Pharmacierge — Pharmacierge is the award-winning digital e-prescribing service chosen by private clinicians to deliver medication to their patients throughout the UK and worldwide. Clinicians create and transfer e-prescriptions to our pharmacy near London's Harley Street, for free delivery to their patients.
Jan Hruska
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.
Taavet Hinrikus is based out of London, England and is the Partner of Plural Platform and Board Member of CoMind. Taavet previously worked at Wise as a Chairman and Co-founder. Taavet Hinrikus attended INSEAD.
Show more...Investment focus
- Industry: FinTech, Software, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Estonia
Investor stats
- Total investments: 135
- Round size: Seed $1.4M–$10M; Series A $6.4M–$45M; Series B $23M–$58M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Lassie — AI that runs the doctor's office.
- Open Cosmos — Open Cosmos design, build and operate space missions, providing straightforward access to high quality satellite data and insights on a global scale.
- Lightyear — Lightyear is a simple and approachable way to invest your money globally without unnecessary barriers and fees.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, United States, India
Investor stats
- Total investments: 40
- Round size: Seed $764k–$7M; Pre-Seed $55k–$4.2M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Stackfix — Stackfix operates as a software comparison platform.
- Rivan Industries — Rivan Industries designs and builds modular, vertically integrated, synthetic fuel plants.
- Asymmetric Security — Asymmetric Security is an AI-native cybersecurity startup specializing in digital forensics and incident response. It combines elite forensic experts with proprietary AI to accelerate investigations, especially Business Email Compromise (BEC) attacks, at less than half the cost of competitors while shrinking timelines from days to hours.
Justin Mateen is the Cofounder and former CMO of Tinder, the world's largest dating platform. In 2021, and 2022 Business Insider ranked Mateen as the best early stage investor in the US, placing him at the number 1 spot on the top 100 list of US Seed Investors both years. In 2020, Forbes included Mateen on their list of the decade's top10 tech entrepreneurs. Fast Company has listed him as one of the most creative people in business.Founded in 2012, Tinder is the highest grossing app on Apple's app store since 2017 and was valued at over $40 Billion dollars in 2021.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Mexico, United Kingdom
Investor stats
- Total investments: 209
- Round size: Seed $1M–$9.5M; Pre-Seed $400k–$3.9M; Series A $6.8M–$30M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Estate Media — Real Estate's Biggest Personalities Under one Roof
- Subquadratic — AI lab leading the subquadratic LLM revolution.
- Hidden Studios — Hidden Studios develops and advertises Fortnite Creative games, with 100M+ plays monthly. The company collaborated with prominent brands and creators, including Skydance, Snoop Dogg, and CaseOh, to deliver engaging gaming experiences. Hidden Studios maintains an active presence on YouTube, sharing content related to their Fortnite Creativeendeavors.
Finn Russell is a Scottish rugby union player.
Show more...Investment focus
- Industry: Fitness, Medical, Wellness
- Stage:Angel, Venture - Series Unknown
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Puresport — Puresport was created to craft the finest, premium-quality natural products to support every element of wellbeing, from pain & recovery, to sleep, focus, mood, stress, and balance.
Will Martin - Founder and Director @ Portfolio Ventures
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Japan
Investor stats
- Total investments: 107
- Round size: Seed $874k–$5.5M; Pre-Seed $650k–$3.7M; Series A $2.3M–$11M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bequest — Digital estate planning made easy for professionals and individuals. Securely protect online accounts, cryptocurrencies, emails, media, documents and more.
- Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
- Robin — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.
One of the UK's leading tech angel investors. Active seed and pre-seed stage angel investor in UK based disruptive tech. Prefers businesses venturing into pastures new and keen investing at the pre product stage whether BtoC or B2B. Twice exited UK based tech entrepreneur with experience operating tech businesses in 20 countries in multiplelanguages. Co-founded Gumtree with Simon Crookall which was acquired by Ebay and Slando acquired by Naspers.
Show more...Investment focus
- Industry: Software, SaaS, Financial Services
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 38
- Round size: Seed $750k–$3.1M; Pre-Seed $690k–$2.1M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Hubflo — Hubflo is building an all-in-one work OS to help small businesses manage their business. Instead of having 10 complicated and expensive pieces of software, Hubflo offers SMB everything they need to run their business (CRM, projects, invoicing, expenses...) in a single comprehensive, simple and affordable platform.
- Tetra AI — Tetra AI is a health technology firm that has created an AI-powered software platform designed to assist hospitals in managing surgical waiting lists and operating room schedules. The system evaluates patient lists, staff availability, and theatre capacity to generate optimized surgical plans that minimize delays and improve resource utilization.It is mainly employed by NHS hospitals and operational teams to enhance elective care performance within the limits of available resources.
- Sidekick — Expertly-managed portfolios for the modern investor
Matt Robinson is the CEO and a co-founder at Nested, a property technology company. Prior to this, he founded GoCardless in 2010 and remains on the board of the recurring payment company.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 80
- Round size: Seed $2M–$7.9M; Pre-Seed $650k–$3M; Series A $6M–$50M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Malga — Malga is an online payment platform that offers fraud protection and payment split services.
- Feather — Feather gives you insurance advice for expats in Germany. Our digital insurance agent will help you get the right insurance policies for your need.
- Malga — Instant access to multiple payment providers with a single integration
Alex Macdonald is the Co-Founder and CEO Sequel. He previously Co-Founded Velocity Black. He attended The University of Manchester.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Pre-Seed, Seed, Series B
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 49
- Round size: Seed $1.2M–$8.5M; Pre-Seed $327k–$2.5M; Series B $11M–$50M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kalder — Kalder is a unified web3 brand loyalty platform for brands and creators to drive meaningful engagement, onboard new users, and reward superfan communities.
- Stelia — Stelia builds distributed AI platforms that scale globally. Research-driven intelligent systems for healthcare, education, and enterprise operations worldwide
- Aurora — The Operating System for High Performance Living
Sachin Agrawal
Show more...Investment focus
- Industry: Medical, Health Care, Health Diagnostics
- Stage:Series A
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.
Johnathan Matlock is Co-Founder Science Angel Syndicate.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 10
- Lead/follow: no public data
Portfolio highlights
- OutSee — We are well-versed in a variety of genomics, AI and cohort analysis techniques. We are also bioinformatics generalists and work with just about any ...
- EnsiliTech — EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing vaccines and biologicals
- Halo Therapeutics — Halo Therapeutics is based in England. Develops safe pan coronavirus antiviral drugs for Covid-19 that can be administered by patients.
Sir Brian Souter is co-founder and Chairman of Stagecoach plc, having retired as Chief Executive in May 2013.Whilst he does not sit with the Souter Investments team in Edinburgh, Sir Brian is active in all investment decision making processes and sits on the boards of our European bus operators (PolskiBus.com and OnniBus.com) and New Zealandtransport group (InMotion).Sir Brian is currently the Vice-President of the Institute of Chartered Accountants of Scotland.
Show more...Investment focus
- Industry: Medical, Commercial, Health Care
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Ryboquin — Ryboquin™ uses its expertise to turn under-developed intellectual property ideas into viable commercial realities. Founded in Scotland, Ryboquin Ltd is a privately held, virtual pharmaceutical company focused on commercialising patented technologies in the area of human cancer medicine.Founded in Scotland, Ryboquin is a privately held, virtualpharmaceutical company focused on commercializing patented technologies in the area of human cancer medicine.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Yusuf Hamied is a Cambridge-educated Chemist and the Non-Executive Chairman of the Board of Directors at Cipla, a large generic pharmaceuticals company founded in 1935 by his father, Khwaja Abdul Hamied. Yusuf became a global celebrity for his role in defying Western multinational pharmaceutical companies in order to provide generic AIDS treatmentsand other drugs to treat poor people in the developing world. After completing his doctorate in 1960, Yusuf joined the family company and vowed to break the dominance of foreign multinationals over the Indian pharmaceutical market by developing cheap generic drugs. Yusuf helped persuade the Indian government to change Indian patent law in 1972, permitting medicines to be copied even if they were under international patent, as long as the process was not the same. The law transformed the Indian pharmaceutical industry, enabling his and other companies to grow by manufacturing generic drugs. In 2001 Yusuf convulsed the global healthcare industry by promising and then delivering a triple drug cocktail, Triomune, that helped fight against HIV and AIDS at prices far lower than those available internationally. Yusuf discusses his subsequent anger when, in 2005, the Indian government brought its patent laws in line with those of the developed world, prohibiting the copying of drugs patented after 1995 without a license and his resentment that he had thereafter “to go with a begging bowl to the multinationals” for licenses. This interview provides not only a personal perspective on how India’s third largest pharmaceutical firm was created, but contributes to the broad debates on the costs and benefits of intellectual property laws, particularly their impact on people who are denied life-saving drugs by their inability to pay for them. Working for Cipla as Managing Director for nearly 52 years, Yusuf was also the 28th richest Indian during one time. ‘CNN-IBN Indian of the year’ and one among the ’25 greatest global living legends’ were the titles that Yusuf won for his reign in the pharma world majorly for making medicines affordable to the poor. Yusuf was awarded with the civil honorary Padma Bhushan from then president APJ Abdul Kalam in the year 2005 for his fight against AIDS, which he often said was going to be as damaging to the society as a massive earthquake would be, if ignored. Yusuf earned his Bachelor's degree (1956), Master's degree (1957) and Ph.D. (1960) in Chemistry from University of Cambridge.
Show more...Investment focus
- Industry: Medical, Medical Device
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- 1inhaler — 1inhaler operates as a developer of drug delivery device.
Carlos Ballarati - Founding partner @ Consulta do Bem
Show more...Investment focus
- Industry: Medical, Database, Consulting
- Stage:Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- OPEN Health — OPEN Health is a healthcare agency that provides market access strategy, health economic modeling and meta-analysis patient engagement, patient-centered outcomes, real-world evidence and data analytics, medical affairs consultancy and strategy, publications planning and delivery, scientific, communications, learning and development.
Graduate, Harvard Univ. and Harvard Business School. Chairman and Managing Director, Mahindra Group. Thought leader in Indian business. Serves on many industry confederations. Initiated the Nanhi Kali programme to provide free education to economically underprivileged girls in India. Co-Founder, Naandi Danone, India's largest safe drinkingwater provider to rural areas. Life Trustee, Board of Naandi Foundation, which provides meals to 1.3 million children daily. Co-Chair, World Economic Forum Annual Meeting 2009. Named among World’s 50 Greatest Leaders, Fortune Magazine (2014); named one of the top 25 most powerful business people in Asia, Fortune Magazine (2011).
Show more...Investment focus
- Industry: Education, Artificial Intelligence, Social Media
- Stage:Seed, Angel, Series A
- Geography: India, United States, United Kingdom
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- Agnikul — Agnikul Cosmos designs and manufactures orbital-class launch vehicles powered by 3D-printed engines. From custom payloads to affordable private launches, we make space access simple, scalable, and mission-focused.
- Harvested Robotics — Harvested Robotics is an ag-tech company that focuses on safeguarding farms from weeds and diseases by lasers, robotics, and AI technology.
- Genrobotics Medical & Mobility — India's top-rated gait trainer, G Gaiter! Our AI-powered, robot assisted gait trainer accelerates neurorehabilitation for faster recovery.
Jim Mellon
Show more...Investment focus
- Industry: Medical, Health Care, Pharmaceutical
- Stage:Series A
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Beckley Psytech — Our mission is to help people suffering from neurological and psychiatric conditions by developing our pipeline of psychedelic compounds.
Charlotte Scott
Show more...Investment focus
- Industry: Medical, Health Care, Pharmaceutical
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Phil founded Health Intelligence in 1996 and maintains a vital role in the company shaping strategy and innovation. After graduating from Keele with an MBA on the Health Executive Programme, Phil spent thirteen years in the NHS as a senior manager responsible for I.T., registration and screening functions. This experience from within the NHS andprivate sector has given him an in-depth understanding of how cross sector population-based solutions can help the NHS overcome key challenges.
Show more...Investment focus
- Industry: Medical, Hospital, Medical Device
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- AI-Sight — AI Sight Limited delivers next-generation AI-powered diabetic eye screening to enhance accuracy, speed, and accessibility across healthcare systems
Harry Glorikian is the General Partner at Scientia Ventures.
Show more...Investment focus
- Industry: SaaS, Content, Analytics
- Stage:Series A
- Geography: United States
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- MarketMuse — Our AI-powered software tells you what content to write (and how much) to leverage your experience and rank higher where competitors are weak.
- Emerald — Take control of your long-term health with Emerald. Get continuous GP support, in-depth screenings, wearable data integration, and a personalised plan to prevent disease and boost longevity.
- Transparency Life Sciences — Transparency Life Sciences, the first all-digital clinical development services company, harnesses crowdsourcing and mobile health technology to advance biopharma drug candidates through clinical trials with unprecedented patient relevance and efficiency.The TLS model is highly scalable and is designed to increase current industry margins of awasteful process that often collects irrelevant data. Drug companies will outsource an estimated $38B of clinical trial services to CROs by 2020, with a CAGR of 9-10%. Yet this robust growth masks significant customer dissatisfaction. Sponsors want clinical trials to be better-designed, technologically advanced, patient-centric, and significantly less expensive, yet change has been limited by an inability to see beyond the current outmoded, site-centric model.As a consequence, only select compounds are being developed in humans, leaving many potential important therapies untested in clinical trials. Rapid advances in digital technology and strong regulatory support create a historic opportunity for TLS to catalyze a fundamental transformation, significantly improving the quality of clinical trials while reducing their cost.
Peter Job is an angel investor.
Show more...Investment focus
- Industry: Medical, Software, Pharmaceutical
- Geography: United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Pangaea Data — Find & connect with more patients, at scale, for therapies, clinical trials and drug discovery studies.
Michael Bibby is Chairman at Bibby Line Group Ltd.
Show more...Investment focus
- Industry: Medical, Hospital, Medical Device
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- AI-Sight — AI Sight Limited delivers next-generation AI-powered diabetic eye screening to enhance accuracy, speed, and accessibility across healthcare systems
Simon Kruger
Show more...Investment focus
- Industry: Medical, Database, Consulting
- Stage:Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- OPEN Health — OPEN Health is a healthcare agency that provides market access strategy, health economic modeling and meta-analysis patient engagement, patient-centered outcomes, real-world evidence and data analytics, medical affairs consultancy and strategy, publications planning and delivery, scientific, communications, learning and development.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Dieter Spälti, Swiss national, born in 1961, Member of the Board of Directors, Member of the Audit Committee, Member of the Governance & Strategy Committee since January 1, 2013. He studied law at the University of Zurich, obtaining a doctorate in 1989. He began his professional career as a credit officer with Bank of New York in New York,before taking up an appointment as CFO of Tyrolit (Swarovski Group), based in Innsbruck and Zurich, in 1991.From 1993 until 2001, he was with McKinsey & Company, ultimately as a partner, and was involved in numerous projects with industrial, financial and technology firms in Europe, the USA and Southeast Asia. In October 2002, he joined Rapperswil-Jona-based Spectrum Value Management Ltd. as a partner, the firm which administers the industrial and private investments of the family of Thomas Schmidheiny.Since 2006, he has been CEO of Spectrum Value Management Ltd. He was elected to the Board of Directors of Holcim Ltd in 2003.
Show more...Investment focus
- Industry: Medical, Software, Health Care
- Stage:Series A
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Ultromics — Unlock the full potential of echocardiography with groundbreaking solution that simplifies echo reporting. Echo that is precise, fast and accurate.
Catherine is an investor, board director and executive coach. She is based in London and works globally.She is an experienced international C-suite executive with a strong track record in the People, DE&I and ESG fields. Together with Jonathan Lenson. she invests in exceptional early-stage tech companies across the UK, US and Israel, andbrings in-depth previous board experience as both an executive and non-executive director.She writes and speaks on topics including the future of work, corporate culture and purpose, diversity and inclusion, and work/life integration.As part of her coaching practice, she is the first UK-based facilitator to be certified in the Fair Play method. Catherine was the first female Managing Partner appointed at SoftBank Investment Advisers, the world’s largest technology investment firm with $175 billion under management in the two SoftBank Vision Funds and SoftBank Latin America Funds. As the founding Chief People Officer for five years (2017-2022), she led the HR, ESG and Real Estate teams globally.An experienced and trusted executive coach at C-suite level, she worked with companies within the Vision Fund portfolio on leadership, talent, DE&I, ESG, and operating challenges, including as a Board Director.Catherine built SBIA’s ESG practice and designed its strategy for Social Impact. She led SoftBank’s early stage venture funds focused on diverse founders, including the $100m+ SB Opportunity Fund (US) and Emerge (EMEA), including as an Investment Committee member.Catherine is a Young Global Leader of the World Economic Forum (Class of 2021) and a founding member of Sustainability30 (which brings together Chief Sustainability Officers from 30 of the world’s leading companies).She spent the formative years of her career at UBS AG, Switzerland’s leading financial services firm, and is proud to have progressed from intern to Managing Director in the same firm. In her final role there, she led Reward for UBS across the UK and EMEA region.
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Seed, Pre-Seed, Grant
- Geography: United Kingdom, Israel
Investor stats
- Total investments: 14
- Lead/follow: no public data
Portfolio highlights
- Roleshare — Roleshare matches freelancers, part-time and fractional workers to job share; helping companies retain and attract coveted skills and talent. Join us!
- Tangent — Tangent: Your bridge from diverse backgrounds to tech sales roles via referrals, coaching, and unique video pitches. Create a free account today!
- Surfboard — Get Dialpad Workforce Management (WFM) software for accurate forecasting, demand-driven scheduling, fair shift planning, and more.
Stephen Bourke
Show more...Investment focus
- Industry: Health Care, Medical, Wellness
- Stage:Pre-Seed, Angel
- Geography: United Kingdom
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Jude — Science-backed food supplement that makes you feel empowered, not embarrassed.
- Habitual — Our diabetes remission programme combines digital therapeutics with diet and habit change. Our personalised programme delivers type 2 diabetes reversal and weight loss.
- Syndi Health — Meet Syndi Health: an all-in-one platform for aggregating, recommending, and paying for digital health services - amplifying your employee wellbeing support with 0% admin.
Elan Katz, CEO at Quick RX.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
Simon Franks is the founder and managing partner of Redbus Ventures and Chairman of the Franks Family Foundation. (www.thefff.org)
Show more...Investment focus
- Industry: FinTech, Health Care, Payments
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 58
- Round size: Seed $586k–$5.7M; Pre-Seed $323k–$1.6M; Series A $5.4M–$23M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- 5Mins — 5Mins is the new microlearning platform that helps your employees build in-demand skills fast with AI-powered personalisation and advanced gamification.
- Oto Health — Take back control of your tinnitus with Oto, the app built by doctors that teaches you how to stop noticing the ringing using clinically proven techniques. Includes CBT, targeted mindfulness, and relaxation. 86% users experience benefits after just 1 month.
- Tolemy Bio — The AI-native virtual cell platform for therapeutic development and manufacture.
Ian Noel - Angel & Growth Investor @ Lingokids
Show more...Investment focus
- Industry: Pet, Education, Film
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 6
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Oja.la — Oja.la is an online learning platform for computer skills in Latin America. Oja.la has developed 1,500 classes.- 70 tech programs, released 16 new programs last month and are planning to double the new release of new courses monthly.
- Holidog — Holidog specializes in the fields of pet sitting, pet boarding, pet walking, giftbox, pet media, and startups. It features a software platform that allows pet owners to interact and find the perfect pet sitters, dog walkers, nannies, or trainers at their convenience and close to their home.It was founded in 2012 and headquartered in New York,United States.
- Lingokids — Enjoyed by 20M+ families monthly, it offers 4000+ interactive games, songs, and shows loved by kids and trusted by grown-ups around the world.
Jag is one of Europe's most active angel investors, and is a Managing Partner at Angel Invest Ventures in Berlin. He's founded several companies (including two exits and a spectacular failure), and invested in over 100 startups over the last six years, including Spire (SPAC), Nutmeg (exit to JPM), Disperse, Eversend, Restack, and Anytype.He’s an ad-man at heart, and spent over a decade as a political strategist advising high-profile politicians, campaigns and corporations across the US and Europe. Jag is fluent in six languages, and can be found on Twitter via @JagSingh
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Pre-Seed, Seed, Angel
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 100
- Round size: Seed $204k–$4.5M; Angel $174k–$377k; Pre-Seed $120k–$1.5M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Konfetti — konfetti is building the leading platform for local workshops and events by empowering workshop providers with customized SaaS solutions
- Strange Loop Labs — Guru automates tax, insurance, and audit processes with generative AI
- Lightning Reach — Lightning Reach is a financial support portal that makes it easy for people to find and apply for a wide range of personalised support in one place. This support can range from; charitable grants, local council schemes, help with bills and the cost of living crisis and benefits.
Martin Varsavsky is the Founder and Chairman of Gameto. He previously worked at Fon as a Chairman. Martin Varsavsky attended Columbia Business School.
Show more...Investment focus
- Industry: Software, Health Care, Social Media
- Stage:Seed, Series A, Angel
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 25
- Round size: Seed $424k–$3.3M; Angel $212k–$1.1M; Series A $4.3M–$77M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Humand — Discover our all-in-one HR solution. Experience the best HR software for digital transformation and enjoy the benefits of centralizing internal procedures!
- Shorta — Descubre series cortas de drama, comedia, romance y suspenso en Shorta y empieza a ver hoy mismo, con nuevos episodios cada semana.
- Betterness — Betterness is Augmented Wellness: intelligence for people, providers, and builders across the Betterness app, Betterness One, and the developer stack.
Timothy T Davis, MD is Board Certified in Physical Medicine and Rehabilitation (Physiatry) and Pain Medicine. The founder of Source Healthcare, Source Surgery Center, Alpha Diagnostics and he is an expert in spine and musculoskeletal disorders as well as interventional pain management to treat neck, back and sports injuries. Dr. Davis hasperformed extensive clinical research using biological therapies such as stem cells and other biologics for spine and joint injuries. He has consulted and invested in SaaS, medical device, biologics, cannabis, and psychedelics sectors.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 10
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bryn Pharma — Bryn Pharma is a pharmaceutical company that offers nasal-based epinephrine for anaphylaxis. Its bi-dose intranasal device is an alternative to epinephrine auto-injectors and is needle-free. It is easy to use and portable enabling patients to treat allergic reactions or anaphylactic reactions.
- Beckley Psytech — Our mission is to help people suffering from neurological and psychiatric conditions by developing our pipeline of psychedelic compounds.
- MycoMedica Life Sciences, PBC — Psychedelic Medicines
Principal at Apax Digital.
Show more...Investment focus
- Industry: Software, SaaS, Rental
- Stage:Series A, Series D, Series E
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 4
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- Guesty — Guesty simplifies the way property managers work.
- Inspectorio — We allow Brands, Retailers, Vendors and Factories to improve Quality, Compliance and Delivery operations with tangible insights and data-driven collaboration.
- MIP Diagnostics — MIP Diagnostics develop and manufacture molecularly imprinted polymers (nanoMIPs) that act as synthetic alternatives to antibodies for IVD and other industries.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!John Lloyd
Show more...Investment focus
- Industry: Health Care, Wellness, Education
- Stage:Seed, Equity Crowdfunding, Venture - Series Unknown
- Geography: United Kingdom
Investor stats
- Total investments: 6
- Round size: Seed $186k–$655k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Thrive — Thrive Mental Wellbeing - Mental Health Services
- Easy Peasy — Get EasyPeasy parenting tips and activities, personalised for you and your 0-5 year old, from our playful community of parents and experts.
- Elemental Software — Elemental is a digital platform that connects patients health and social care professionals and community health & wellness providers.Health Professionals are able to generate digital social prescriptions for citizens with chronic health risks such as depression, social isolation, type 2 diabetes and obesity, connecting them with qualityassured providers who deliver community based interventions across the domains of exercise, diet/nutrition, social support and mental health.The software is designed as a multi-tenanted cloud service and so can be implemented rapidly. It is highly parameterised and can be customised to suit an individual organisation's functional requirements without compromising its technological core.
Julien is an investor at Felix Capital where he focuses on SaaS (Worktech in particular) and gaming investments.Before joining Felix, Julien Codorniou spent 11 years at Facebook where he led the global platform partnerships team, helping Facebook partners to build, grow and monetize their mobile apps and games. From 2016 to 2021, he has beenserving as Vice President of Workplace. Under his leadership, Workplace went from 0 to 9 million paid subscribers at companies like Walmart, Grab, GSK, Nestlé, Chevron, MercadoLibre, ServiceNow, Astrazeneca, Lixil, Spotify, Save the Children and many more globally. Julien started his career in finance and before Facebook he was Director of Business Development at Microsoft Corp.Since 2012, Julien has served on the board of the French media group Le Monde. He is the co-author of the book: "The Kelkoo.com success story"published by Pearson in 2005.His former investments, as business angel include companies like TripleDot Studios, Bloom & Wild, Pigment, Xentral, Homesome, Olio, Peanut, Nabla, Curio, Linktree, Airlift Technologies and Sunday.He grew up in France and now lives in London with his wife and their two boys.
Show more...Investment focus
- Industry: Software, E-Commerce, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: France, United Kingdom, United States
Investor stats
- Total investments: 56
- Round size: Seed $1M–$8M; Pre-Seed $125k–$2.7M; Series A $3.3M–$23M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Claimy — Integrate Claimy to unlock the full potential of your catalogue, recover missing royalties, and gain real-time insights into your performances.
- Jolly — Jolly is a rewards platform for the workplace that incentivizes employee performance. It implements performance-based incentives to increase employees utilization, compliance, referrals, and loyalty.
- Arlequin AI — Unlock actionable insights from complex social data to drive strategic decisions using our AI models.
Curtis Chambers
Show more...Investment focus
- Industry: Internet, Artificial Intelligence, GPS
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 8
- Round size: Series A $11M–$18M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nana Academy — Nana is a vertically integrated student-to-operator trade skills school, today focused on Appliance Repair. We work with some of the 35 million people who will lose their jobs by 2030 to tech automation, teaching them trade skills, building their experience through our mentorship program, and connecting them to good jobs on our marketplace. Byperfecting this pipeline and teaching life skills to a new generation of tradespeople, we are accelerating the retooling of America’s workforce and creating millions of economic opportunities.
- TruckMap — The routing and revenue platform for truck drivers.
- Juggle Jobs — Find your dream remote job from the best companies in the UK, hand-picked by our trusted experts at WFH Jobs.
Bashar Hamood is a Venture Partner at FasterCapital. He previously worked as an Associate Director at Logica. He attended Heriot-Watt University.
Show more...Investment focus
- Industry: Information Technology, Software, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 617
- Round size: Seed $10k–$2M; Pre-Seed $5k–$413k; Series A $33k–$5M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- EcoBites — EcoBites is a subscription service that delivers sustainably sourced and eco-friendly packaged snacks and meals to consumers doorsteps.
- Lawyeree — A platform offering AI legal advice to clients and allowing clients to be connected with the best lawyers.
- ZohoOptimizer AI — ZohoOptimizer AI is a platform designed to enhance Zoho’s suite of business applications by providing AI-driven process automation.
Carlos Gallardo is a president at the European Federation of Pharmaceutical Industry Associations.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A
- Geography: Spain, United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Amelia Virtual Care — Psious develops a virtual reality platform designed to bring value to mental health treatment. The company's platform uses hyper-realistic virtual environments to treat anxiety disorders by means of virtual exposure therapy, enabling professionals to improve mental health therapies.
- TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
Andrew Fisher is the Founder & Chief Executive Officer of Protonify Corporation. He previously worked at Wesley Clover International Corporation as an Executive Vice President. Andrew Fisher attended the University of Victoria.
Show more...Investment focus
- Industry: Medical, Life Science, Biotechnology
- Stage:Series A
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MIP Diagnostics — MIP Diagnostics develop and manufacture molecularly imprinted polymers (nanoMIPs) that act as synthetic alternatives to antibodies for IVD and other industries.
Imran Hakim, Optometrist, Inventor, and Serial Entrepreneur.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
Arjun JJ Desai is based out of Miami, Florida, and is the CEO of Lotus Neuro. Arjun previously worked at Avinger as a Chief Medical Officer.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed
- Geography: United Kingdom
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
Jim Breyer is based out of Austin, Texas, and is the Founder & CEO of Breyer Capital. Jim previously worked at IDG Capital as Co-Chairman. Jim Breyer attended Harvard Business School.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Series B, Series A, Seed
- Geography: United States, United Kingdom, Singapore
Investor stats
- Total investments: 105
- Round size: Seed $6M–$150M; Series A $7.5M–$30M; Series B $13M–$80M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- World Labs — World Labs is an AI startup that can analyze visual data with comprehension akin to a person's, a substantial advancement above existing capacities.
- Circuit — Your best people can't be everywhere. Their expertise can. Circuit helps manufacturing and service teams quote, troubleshoot, and support with confidence.
- Advanced Machine Intelligence — AMI - Advanced Machine Intelligence - builds world-model-based AI that understands the real world. We develop safe, controllable intelligent systems for industry, robotics, healthcare, and beyond.
Tim Ringel is a Global CEO at Meet The People. He attended the University of Duisburg-Essen from 1996 to 2001.
Show more...Investment focus
- Industry: E-Commerce, FinTech, Software
- Stage:Seed, Series A, Angel
- Geography: Germany, United States, Sweden
Investor stats
- Total investments: 15
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Klarna — Einkaufen, was du willst. Bezahlen, wie du willst. Klarna bietet dir verschiedene Zahlungsarten an. Du entscheidest, welche am besten zu dir passt.
- yamuntu — Get sponsored by brands, save money with your Instagram story and inspire your friends!
- One Earth Rising™ — One Earth Rising and its team come from the core gaming market and have built games with millions of players on PlayStation, Nintendo Switch, and Xbox. The company's Ownable Game Assets transform temporary game purchases into lasting, tradeable collections while connecting digital and real-world engagement.
Medical Angel investor funding in United Kingdom at a glance
Stats across 132 deals from 165 investors.
Access all 165 angel investors in United Kingdom Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Angel Investors in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 165 angel investors investing in United Kingdom Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!